Fusobacterium

Fusobacterium is a genus of anaerobic, Gram-negative bacteria that are part of the normal flora of the human oral cavity, gastrointestinal tract, and female genital tract. These bacteria are known for their spindle-shaped appearance and are implicated in various human infections.
Characteristics[edit]
Fusobacterium species are non-spore-forming, non-motile, and obligate anaerobes. They are Gram-negative rods that can appear spindle-shaped under the microscope. These bacteria are known for their ability to produce butyric acid as a metabolic byproduct.
Pathogenicity[edit]
Fusobacterium species are associated with several human diseases. They are known to cause periodontal diseases, such as gingivitis and periodontitis, due to their presence in dental plaque. Additionally, they are implicated in more serious infections such as Lemierre's syndrome, which is characterized by thrombophlebitis of the internal jugular vein.
Fusobacterium necrophorum[edit]
Fusobacterium necrophorum is one of the most pathogenic species within this genus. It is a common cause of Lemierre's syndrome and can lead to severe infections, including septicemia and abscess formation.
Fusobacterium nucleatum[edit]
Fusobacterium nucleatum is another significant species, often found in the oral cavity. It plays a role in periodontal disease and has been linked to adverse pregnancy outcomes, such as preterm birth.
Clinical Significance[edit]
Fusobacterium infections are typically treated with antibiotics, such as metronidazole or beta-lactam antibiotics. Due to their anaerobic nature, these bacteria are often involved in polymicrobial infections, requiring broad-spectrum antibiotic therapy.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian